K. T. J. Loones et al. / Tetrahedron 63 (2007) 8954–8961
8959
0
0
0
0
.037 g, 4 mol %), and aminopyrazine (2d) (1.8 mmol,
ꢀ
4.3.2. Diquino[1,2-a;2 ,3 -d]imidazole (7b). The general
procedure was followed using 2-aminoquinoline (2b)
(1.8 mmol, 0.259 g). Yield 0.343 g (85%); brown solid;
.171 g). Yield 0.267 g (81%); yellow solid; mp: 246 C;
1
H NMR (400 MHz, CDCl ): d 9.33 (1H, d, J¼1.6 Hz,
3
ꢀ
1
H ), 8.84 (1H, s, H ), 8.77 (1H, dd, J¼4.6, 1.6 Hz, H ),
mp: 237 C, H NMR (400 MHz, CDCl ): d 8.95 (1H, s,
3
1
11
3
8
.28 (1H, br d, J¼8.6 Hz, H ), 8.14 (1H, dd, J¼8.4,
H ), 8.51 (1H, d, J¼8.3 Hz, H ), 8.30 (1H, d, J¼8.5 Hz,
7
6
8
1
.2 Hz, H ), 8.04 (1H, d, J¼4.6 Hz, H ), 7.82 (1H, ddd,
H ), 8.05 (1H, d, J¼8.2 Hz, H ), 7.83 (2H, m, H , H ),
1
0
4
2
5
9
11
J¼8.6, 6.7, 1.2 Hz, H ), 7.63 (1H, br dd, J¼8.4, 6.7 Hz,
7.82 (1H, d, J¼9.5 Hz, H ), 7.73 (1H, dd, J¼8.5, 6.7 Hz,
8
12
1
3
H ); C NMR (100 MHz, CDCl ): d 146.6, 145.4, 144.7,
9
H ), 7.68 (1H, d, J¼9.5 Hz, H ), 7.54 (1H, dd, J¼8.2,
3
3
13
1
3
1
1
2
42.8, 135.5, 129.3, 128.7, 128.6, 128.5, 127.7, 126.9,
25.6, 117.6; HRMS (ESI) for C H N [M+H] calcd
21.0827, found 221.0832.
6.7 Hz, H ), 7.51 (1H, dd, J¼7.8, 7.5 Hz, H ); C NMR
4
10
+
(100 MHz, CDCl ): 157.2, 153.8, 146.8, 135.8, 134.6,
3
1
3
9
4
130.8, 130.1, 129.1, 128.7, 128.0, 124.7, 124.6 (2Cs),
123.8, 123.0, 119.7, 117.7, 114.8; HRMS (ESI) for
C H N [M+H] calcd 270.1031, found 270.1038.
18 12 3
0
0
+
4
.2.5. Pyridazino[6 ,1 :2,3]imidazo[4,5-b]quinoline (4e).
The general procedure was followed using Pd(OAc)2
0.06 mmol, 0.013 g, 4 mol %), XANTPHOS (0.06 mmol,
0
0
(
4.3.3. Isoquino[2 ,1 :1,2]imidazo[4,5-b]quinoline (7c).
The general procedure was followed using 1-aminoisoqui-
noline (2c) (1.8 mmol, 0.259 g). Yield 0.363 g (90%); brown
0
0
.035 g, 4 mol %), and 3-aminopyridazine (2e) (1.8 mmol,
ꢀ
1
.171 g). Yield 0.307 g (93%); brown solid; mp: 199 C; H
ꢀ
1
NMR (400 MHz, CDCl ): d 8.76 (1H, s, H ), 8.52 (1H, dd,
3
solid; mp: 304 C (decomp.); H NMR (400 MHz, CDCl ):
3
11
J¼4.0, 1.4 Hz, H ), 8.42 (1H, d, J¼8.6 Hz, H ), 8.12 (1H,
d 8.97 (1H, d, J¼6.9 Hz, H or H ), 8.51 (1H, s, H ), 8.34
3
7
1
4
8
d, J¼8.3 Hz, H ), 8.06 (1H, dd, J¼9.6, 1.4 Hz, H ), 7.80
(1H, d, J¼8.6 Hz, H ), 8.22 (1H, d, J¼7.3 Hz, H ), 8.03
1
0
1
12
6
(
1H, dd, J¼8.6, 6.8 Hz, H ), 7.61 (1H, dd, J¼8.3, 6.8 Hz,
(1H, d, J¼8.3 Hz, H ), 7.78ꢁ7.72 (4H, m, H or H , H ,
8
9 4 1 2
1
3
H ), 7.40 (1H, dd, J¼9.6, 4.0 Hz, H ); C NMR (100 MHz,
H , H ), 7.54 (1H, br dd, J¼8.3, 6.7 Hz, H ), 7.12 (1H,
5 3
9
2
3 11 10
1
3
CDCl ): d 146.7, 145.5, 144.2, 141.7, 134.6, 129.1, 128.9,
3
d, J¼7.3 Hz, H ); C NMR (100 MHz, CDCl ): d 157.1,
128.4, 128.2, 127.0, 126.6, 125.3, 124.6; HRMS (ESI) for
C H N [M+H] calcd 221.0827, found 221.0832.
153.4, 147.6, 132.7, 131.8, 129.5, 128.7, 128.4, 127.7,
127.1, 126.8, 124.5, 124.4, 123.3, 123.0, 121.6, 115.4,
+
1
3 9 4
+
111.5; HRMS (ESI) for C H N [M+H] calcd
270.01031, found 270.1029.
1
8 12 3
4
.3. General procedure for the synthesis of pyrido-
0 0
[
1 ,2 :1,2]imidazo[4,5-b]quinoline and its benzo and
0
The general procedure was followed using aminopyrazine
0
aza analogs via an orthogonal tandem intermolecular
Pd- and intramolecular Cu-catalyzed amination
4.3.4. Pyrazino[1 ,2 :1,2]imidazo[4,5-b]quinoline (7d).
(
mp: 338 C (decomp.); H NMR (400 MHz, CDCl ): d 9.46
2d) (1.8 mmol, 0.171 g). Yield 0.046 g (14%); yellow solid;
ꢀ
1
A round-bottomed flask of 50 mL was charged with
Pd (dba) (0.030 mmol, 0.028 g, 2.0 mol %), XANTPHOS
3
(1H, d, J¼1.5 Hz, H ), 8.81 (1H, s, H ), 8.46 (1H, dd,
2
3
4
11
(
obtained mixture was flushed with N for 10 min under mag-
0.066 mmol, 0.038 g, 4.4 mol %), and DME (5 mL). The
J¼4.6, 1.5 Hz, H ), 8.39 (1H, d, J¼8.8 Hz, H ), 8.11 (1H,
2
7
d, J¼8.2 Hz, H ), 8.10 (1H, d, J¼4.6 Hz, H ), 7.85 (1H,
2
10 1
netic stirring. Meanwhile a pressure tube of 80 mL was
charged with CuI (0.15 mmol, 0.028 g, 10 mol %), 2,3-di-
bromoquinoline (5) (1.5 mmol, 0.355 g), amidine (2)
(1.8 mmol), and cesium carbonate (6.0 mmol, 1.955 g). To
this mixture, the preformed Pd-catalyst was added under
br dd, J¼8.8, 6.7 Hz, H ), 7.62 (1H, br dd, J¼8.2, 6.7,
9 3
8
1
3
H ); C NMR (100 MHz, CDCl ): d 155.9, 149.6, 146.4,
146.1, 129.8, 129.7, 128.0, 127.4, 125.4, 124.6, 120.9,
+
118.8, 118.2; HRMS (ESI) for C H N [M+H] calcd
1
3 9 4
221.0827, found 221.0832.
an N flow. The 50 mL flask was subsequently rinsed with
2
0
0
2
with N for 5 min, sealed, and heated (oil bath temperature:
ꢂ5 mL DME. Then the resulting mixture was flushed
4.3.5. Pyridazino[1 ,6 :1,2]imidazo[4,5-b]quinoline (7e).
The general procedure was followed using 3-aminopyrid-
azine (2e) (1.8 mmol, 0.171 g). Yield 0.231 g (70%); brown
2
ꢀ
1
60 C) under vigorous magnetic stirring for 24 h. After
ꢀ
1
cooling down to room temperature, DME was removed
by evaporation. Silica gel (1.5 g) was mixed with the
crude product. This solid mixture was brought on top of a sil-
ica gel column and eluted with dichloromethane/methanol
solid; mp: 217 C (decomp.); H NMR (400 MHz, CDCl ):
3
d 8.94 (1H, s, H ), 8.45 (1H, dd, J¼4.1, 1.3 Hz, H ), 8.36
1
1
2
(1H, d, J¼8.7 Hz, H ), 8.16 (1H, dd, J¼9.5, 1.3 Hz, H ),
7
4
8.11 (1H, br d, J¼8.2 Hz, H ), 7.81 (1H, dd, J¼8.7,
1
0
(97:3).
6.7 Hz, H ), 7.58 (1H, dd, J¼8.2, 6.7 Hz, H ), 7.43 (1H,
8
9
1
3 3
3
dd, J¼9.5, 4.1 Hz, H ); C NMR (100 MHz, CDCl ):
0
0
4
.3.1. Pyrido[1 ,2 :1,2]imidazo[4,5-b]quinoline (7a). The
general procedure was followed using 2-aminopyridine
2a) (1.8 mmol, 0.169 g). Yield 0.263 g (80%); yellow solid;
d 154.9, 148.9, 148.3, 141.1, 129.5, 129.2, 128.3, 126.5,
124.9, 124.8, 124.4, 123.3, 118.4; HRMS (ESI) for
+
(
C H N [M+H] calcd 221.0827, found 221.0817.
13 9 4
ꢀ
1
mp: 294 C (decomp.), H NMR (400 MHz, CDCl ): d 8.62
3
(
1H, s, H ), 8.56 (1H, d, J¼6.8 Hz, H ), 8.33 (1H, d,
4.4. General procedure for the synthesis of pyrido-
6
8
0
0
J¼8.7 Hz, H ), 8.03 (1H, d, J¼8.2 Hz, H ), 7.79 (1H, d,
[1 ,2 :1,2]imidazo[4,5-b]quinoline and its benzo and
aza analogs via an auto-tandem inter- and intramole-
cular Pd-catalyzed amination
2
5
J¼9.3 Hz, H ), 7.77 (1H, dd, J¼8.7, 6.8 Hz, H ), 7.60
1
1
3
(
1H, dd, J¼9.3, 6.8 Hz, H ), 7.53 (1H, dd, J¼8.2, 6.8 Hz,
1
0
1
3
H ), 6.92 (1H, t, J¼6.8 Hz, H ); C NMR (100 MHz,
4 9
CDCl ): d 157.2, 153.7, 148.5, 133.1, 129.4, 128.9, 127.9,
3
A round-bottomed flask of 50 mL was charged with
Pd (dba) (0.030 mmol, 0.028 g, 2.0 mol %), XANTPHOS
(9,9-dimethyl-4,5-bis(diphenylphosphanyl)-9H-xanthene)
1
(
26.7, 124.3, 123.7, 122.2, 118.4, 116.5, 110.6; HRMS
ESI) for C H N [M+H] calcd 220.0875, found
2
3
+
1
4 10 3
2
20.0864.
(0.066 mmol, 0.038 g, 4.4 mol %), and DME (5 mL). The